212 related articles for article (PubMed ID: 26525786)
1. Reactive Oxygen Species Contribute to the Bactericidal Effects of the Fluoroquinolone Moxifloxacin in Streptococcus pneumoniae.
Ferrándiz MJ; Martín-Galiano AJ; Arnanz C; Zimmerman T; de la Campa AG
Antimicrob Agents Chemother; 2016 Jan; 60(1):409-17. PubMed ID: 26525786
[TBL] [Abstract][Full Text] [Related]
2. The fluoroquinolone levofloxacin triggers the transcriptional activation of iron transport genes that contribute to cell death in Streptococcus pneumoniae.
Ferrándiz MJ; de la Campa AG
Antimicrob Agents Chemother; 2014; 58(1):247-57. PubMed ID: 24145547
[TBL] [Abstract][Full Text] [Related]
3. Reactive Oxygen Species Production Is a Major Factor Directing the Postantibiotic Effect of Fluoroquinolones in Streptococcus pneumoniae.
García MT; Valenzuela MV; Ferrándiz MJ; de la Campa AG
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31160286
[TBL] [Abstract][Full Text] [Related]
4. Factors contributing to hydrogen peroxide resistance in Streptococcus pneumoniae include pyruvate oxidase (SpxB) and avoidance of the toxic effects of the fenton reaction.
Pericone CD; Park S; Imlay JA; Weiser JN
J Bacteriol; 2003 Dec; 185(23):6815-25. PubMed ID: 14617646
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial activity of a DNA topoisomerase I inhibitor versus fluoroquinolones in Streptococcus pneumoniae.
Valenzuela MV; Domenech M; Mateos-Martínez P; González-Camacho F; de la Campa AG; García MT
PLoS One; 2020; 15(11):e0241780. PubMed ID: 33141832
[TBL] [Abstract][Full Text] [Related]
6. [MALDI-ToF mass-spectrometry in analysis of genetically determined resistance of Streptococcus pneumoniae to fluoroquinolones].
Malakhova MV; Vereshchagin VA; Il'ina EN; Govorun VM; Filimonova OIu; Grudinina SA; Sidorenko SV
Antibiot Khimioter; 2007; 52(1-2):10-7. PubMed ID: 18461803
[TBL] [Abstract][Full Text] [Related]
7. [Fluoroquinolone resistance determining region mutation in Streptococcus pneumonia isolates].
Zhang FF; Zhao CJ; Wang H
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):940-4. PubMed ID: 24503427
[TBL] [Abstract][Full Text] [Related]
8. Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates.
Smith HJ; Walters M; Hisanaga T; Zhanel GG; Hoban DJ
Antimicrob Agents Chemother; 2004 Oct; 48(10):3954-8. PubMed ID: 15388458
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of bacterial kill when modelling the bronchopulmonary pharmacokinetic profile of moxifloxacin and levofloxacin against parC-containing isolates of Streptococcus pneumoniae.
Deryke CA; Du X; Nicolau DP
J Antimicrob Chemother; 2006 Sep; 58(3):601-9. PubMed ID: 16857688
[TBL] [Abstract][Full Text] [Related]
10. Pyruvate oxidase of Streptococcus pneumoniae contributes to pneumolysin release.
Bryant JC; Dabbs RC; Oswalt KL; Brown LR; Rosch JW; Seo KS; Donaldson JR; McDaniel LS; Thornton JA
BMC Microbiol; 2016 Nov; 16(1):271. PubMed ID: 27829373
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism and regulation of the spxB (pyruvate oxidase) virulence factor gene by a CBS-HotDog domain protein (SpxR) in serotype 2 Streptococcus pneumoniae.
Ramos-Montañez S; Tsui HC; Wayne KJ; Morris JL; Peters LE; Zhang F; Kazmierczak KM; Sham LT; Winkler ME
Mol Microbiol; 2008 Feb; 67(4):729-46. PubMed ID: 18179423
[TBL] [Abstract][Full Text] [Related]
12. Effect of hydrogen peroxide production and the Fenton reaction on membrane composition of Streptococcus pneumoniae.
Pesakhov S; Benisty R; Sikron N; Cohen Z; Gomelsky P; Khozin-Goldberg I; Dagan R; Porat N
Biochim Biophys Acta; 2007 Mar; 1768(3):590-7. PubMed ID: 17292324
[TBL] [Abstract][Full Text] [Related]
13. Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme.
Canton R; Morosini M; Enright MC; Morrissey I
J Antimicrob Chemother; 2003 Dec; 52(6):944-52. PubMed ID: 14585861
[TBL] [Abstract][Full Text] [Related]
14. In vitro pharmacodynamic evaluation of garenoxacin against quinolone-resistant Streptococcus pneumoniae.
Fukuda Y; Takahata M; Sugiura Y; Shinmura Y; Nomura N
Int J Antimicrob Agents; 2012 Feb; 39(2):163-7. PubMed ID: 22088660
[TBL] [Abstract][Full Text] [Related]
15. In vitro selection of resistance in Streptococcus pneumoniae at in vivo fluoroquinolone concentrations.
De Vecchi E; Nicola L; Ossola F; Drago L
J Antimicrob Chemother; 2009 Apr; 63(4):721-7. PubMed ID: 19218275
[TBL] [Abstract][Full Text] [Related]
16. Novel Ser79Leu and Ser81Ile substitutions in the quinolone resistance-determining regions of ParC topoisomerase IV and GyrA DNA gyrase subunits from recent fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates.
Korzheva N; Davies TA; Goldschmidt R
Antimicrob Agents Chemother; 2005 Jun; 49(6):2479-86. PubMed ID: 15917550
[TBL] [Abstract][Full Text] [Related]
17. In vitro pharmacodynamics of moxifloxacin versus levofloxacin against 4 strains of Streptococcus pneumoniae: 1 wild type, 2 first-step parC mutants, and 1 pump mutant.
Schafer J; Hovde LB; Simonson D; Rotschafer JC
Diagn Microbiol Infect Dis; 2008 Feb; 60(2):155-61. PubMed ID: 17910998
[TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolone resistance in Streptococcus pneumoniae: area under the concentration-time curve/MIC ratio and resistance development with gatifloxacin, gemifloxacin, levofloxacin, and moxifloxacin.
LaPlante KL; Rybak MJ; Tsuji B; Lodise TP; Kaatz GW
Antimicrob Agents Chemother; 2007 Apr; 51(4):1315-20. PubMed ID: 17296740
[TBL] [Abstract][Full Text] [Related]
19. Influence of the spxB gene on competence in Streptococcus pneumoniae.
Bättig P; Mühlemann K
J Bacteriol; 2008 Feb; 190(4):1184-9. PubMed ID: 18065543
[TBL] [Abstract][Full Text] [Related]
20. In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae.
Louie A; Brown DL; Liu W; Kulawy RW; Deziel MR; Drusano GL
Antimicrob Agents Chemother; 2007 Nov; 51(11):3988-4000. PubMed ID: 17846144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
